Jay Caplan

Company: Fractyl Health

Job title: President & Founder

Seminars:

Leveraging Gene Therapy Approaches to Promote Durable Weight Loss & Overcome Challenges in Patient Adherence 10:00 am - 10:30 am

Advancing incretin-based therapies designed to be a one-time therapy for long-term remission of type 2 diabetes Permanently altering metabolic hormone response in pancreatic islet cells Uncovering strategies to maintain body composition and glycemia after semaglutide withdrawalRead more

day: Day Two

Panel Discussion: Navigating Best Practices to Promote Patient Adherence to GLP-1s for Good Quality, Durable Weight Loss 2:00 pm - 2:30 pm

Discussing the value of support in lifestyle choices to support the healthy and productive administration of GLP-1s – should it be compulsory to provide lifestyle management programs along with GLP-1 therapeutics Understanding financial barriers to adherence such as changing insurance landscape for weight loss drugs Highlighting the importance of education and support to ensure that…Read more

day: Day Two

Panel Discussion: Discussing the Future of GLP-1s: Applications Beyond Obesity & Future Challenges 3:00 pm - 3:30 pm

Advancing the reach of GLP-1-based treatments past obesity and metabolism, into neurology and beyond Exploring the maintenance of scientific validity in future studies of GLP-1s as the percentage of the population taking these therapies increases Considering the impact of generic forms of GLP-1s on the current commercial landscape of the incretin fieldRead more

day: Day Two